Immuneering (IMRX) Assets (2020 - 2026)
Immuneering (IMRX) posted Assets of $202.06 million for Q2 2026, up 404.4% from $40.06 million a year earlier but down 5.9% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Immuneering's Assets came in at $231.99 million, up 340.1% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 43.3% (FY2020 to FY2025).
- In prior years, Immuneering's Assets was $52.71 million in FY2024 (-48.6%), $102.58 million in FY2023 (-16.2%), $122.37 million in FY2022 (-26.6%) and $166.7 million in FY2021 (+333.9%).
- Quarterly Assets has run from a low of $40.06 million in Q2 2025 to a high of $241.06 million in Q3 2025 over five years.
- On a year-over-year basis, Assets has increased in each of the last four quarters, with growth averaging 142.6% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q2 2026, with growth of 404.4%; the weakest was Q4 2024, with a decline of 48.6%.
- According to Business Quant data, Assets for the three prior quarters was $214.81 million (Q1 2026), $231.99 million (Q4 2025) and $241.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Immuneering | 269.14 Mn | 269.14 Mn | - | 202.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 202.06 Mn |
| Mar 31, 2026 | 214.81 Mn |
| Dec 31, 2025 | 231.99 Mn |
| Sep 30, 2025 | 241.06 Mn |
| Jun 30, 2025 | 40.06 Mn |
| Mar 31, 2025 | 50.68 Mn |
| Dec 31, 2024 | 52.71 Mn |
| Sep 30, 2024 | 68.56 Mn |
| Jun 30, 2024 | 77.09 Mn |
| Mar 31, 2024 | 87.98 Mn |
| Dec 31, 2023 | 102.58 Mn |
| Sep 30, 2023 | 113.88 Mn |
| Jun 30, 2023 | 124.90 Mn |
| Mar 31, 2023 | 107.70 Mn |
| Dec 31, 2022 | 122.37 Mn |
| Sep 30, 2022 | 133.69 Mn |
| Jun 30, 2022 | 142.05 Mn |
| Mar 31, 2022 | 152.45 Mn |
| Dec 31, 2021 | 166.70 Mn |
| Sep 30, 2021 | 164.04 Mn |
API Access
Immuneering Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();